Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)

China flag China · Delayed Price · Currency is CNY
4.130
+0.090 (2.23%)
Jun 2, 2026, 3:05 PM CST
Market Cap2.10B -40.6%
Revenue (ttm)385.04M -4.5%
Net Income27.53M -10.7%
EPS0.05 -15.9%
Shares Out 507.51M
PE Ratio80.79
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,956,000
Open3.770
Previous Close4.040
Day's Range3.770 - 4.170
52-Week Range3.630 - 8.430
Beta-0.07
Analystsn/a
Price Targetn/a
Earnings DateAug 26, 2026

About SHE:002198

Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Shufeng Huoluo tablets, Tiaomeng Huoxue tablets, etc. Guangdong Jiaying Pharmaceutical Co., Ltd. was founded in 2003 and is based in Meiz... [Read more]

Sector Healthcare
Founded 2003
Employees 594
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002198
Full Company Profile

Financial Performance

In 2025, SHE:002198's revenue was 383.75 million, an increase of 2.02% compared to the previous year's 376.17 million. Earnings were 30.48 million, an increase of 47.87%.

Financial Statements